Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or Without HLA-Ia Reactivity

Overview

Journal Antibodies (Basel)

Date 2024 Feb 23

PMID 38390869

Authors

Mepur H Ravindranath

Narendranath M Ravindranath

Carly J Amato-Menker

Fatiha El Hilali

Edward J Filippone

Affiliations

Soon will be listed here.

Abstract

Previous investigators have used various anti-HLA-F monoclonal antibodies (mAbs) to demonstrate that the tissue distribution of HLA-F is highly restricted. Notably, these mAbs differed in their immunodiagnostic capabilities. Specifically, mAbs Fpep1.1 and FG1 detected HLA-F intracellularly in B cells but not on the cell surface, whereas mAb 3D11 detected HLA-F on the cell surface. The presence of HLA-F on T cells was recognized by mAb FG1 but not by mAb Fpep1.1. mAb 3D11 detected HLA-F on the cell surface of activated B cells and on peripheral blood lymphocytes, but not on the normal cells. Importantly, mAb 3D11 revealed that HLA-F exists as a heavy chain (HC) monomer, rather than as an HC associated with B2m. Although these mAbs are believed to be specific to HLA-F, their monospecificity has not been formally established, which is critical for immunodiagnostic and therapeutic purposes. Previously, we investigated the diversity of HLA class I reactivities of anti-HLA-E mAbs using HLA-I coated multiplex bead assays on a Luminex platform. We reported that more than 80% of the HLA-E mAbs were cross-reactive with other HLA-I molecules, with exceptionally few truly HLA-E-monospecific mAbs. In the present investigation, we generated IgG mAbs against HCs of HLA-F in Balb/C mice and examined the cross-reactivity of anti-HLA-F mAbs with other HLA-I alleles using a multiplex bead assay on the Luminex platform. Beads coated with an array of HLA homo- and heterodimers of different HLA-Ia (HLA-A, HLA-B, and HLA-C) and Ib (HLA-E, HLA-F, and HLA-G) alleles were used to examine the binding of the anti-HLA-F mAbs. Only two mAbs were HLA-F monospecific, and five were HLA-Ib restricted. Several anti-HLA-F mAbs cross-reacted with HLA-E ( = 4), HLA-G ( = 3), HLA-Ia alleles ( = 9), HLA-G and HLA-Ia ( = 2), and HLA-Ib and HLA-Ia ( = 6). This monospecificity and polyreactivity were corroborated by the presence of HLA-F monospecific and HLA-I-shared sequences. This study emphasizes the need to monitor the mono-specificity of HLA-F for reliable immunodiagnostics and passive immunotherapy.

References

Feng E, Liang T, Wang X, Du J, Tang K, Wang X . Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples. J Neuroinflammation. 2019; 16(1):33. PMC: 6373026. DOI: 10.1186/s12974-019-1418-3. View

Setini A, Beretta A, De Santis C, Meneveri R, Martayan A, Mazzilli M . Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin. Hum Immunol. 1996; 46(2):69-81. DOI: 10.1016/0198-8859(96)00011-0. View

Allen R, OCallaghan C, McMichael A, Bowness P . Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol. 1999; 162(9):5045-8. View

Ravindranath M, Jucaud V, Ferrone S . Monitoring native HLA-I trimer specific antibodies in Luminex multiplex single antigen bead assay: Evaluation of beadsets from different manufacturers. J Immunol Methods. 2017; 450:73-80. PMC: 8715512. DOI: 10.1016/j.jim.2017.07.016. View

Jucaud V, Ravindranath M, Terasaki P . Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions. Transplantation. 2016; 101(4):764-777. PMC: 7228605. DOI: 10.1097/TP.0000000000001420. View

Hrbac T, Kopkova A, Siegl F, Vecera M, Ruckova M, Kazda T . HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation. Cancer Genomics Proteomics. 2022; 19(2):151-162. PMC: 8865046. DOI: 10.21873/cgp.20311. View

Geraghty D, Wei X, Orr H, Koller B . Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J Exp Med. 1990; 171(1):1-18. PMC: 2187653. DOI: 10.1084/jem.171.1.1. View

Harada A, Ishigami S, Kijima Y, Nakajo A, Arigami T, Kurahara H . Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer. Pathol Int. 2015; 65(11):569-74. DOI: 10.1111/pin.12343. View

Madrigal J, Belich M, Benjamin R, Little A, Hildebrand W, Mann D . Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells. J Exp Med. 1991; 174(5):1085-95. PMC: 2119017. DOI: 10.1084/jem.174.5.1085. View

10.

Ravindranath M, Pham T, El-Awar N, Kaneku H, Terasaki P . Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies. Mol Immunol. 2010; 48(4):423-30. DOI: 10.1016/j.molimm.2010.09.011. View

11.

Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H . Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 2003; 171(3):1376-84. DOI: 10.4049/jimmunol.171.3.1376. View

12.

Dulberger C, McMurtrey C, Holzemer A, Neu K, Liu V, Steinbach A . Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017; 46(6):1018-1029.e7. PMC: 5523829. DOI: 10.1016/j.immuni.2017.06.002. View

13.

Bird L, Peh C, Kollnberger S, Elliott T, McMichael A, Bowness P . Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol. 2003; 33(3):748-59. DOI: 10.1002/eji.200323678. View

14.

Ravindranath M, Ravindranath N, Selvan S, Hilali F, Amato-Menker C, Filippone E . Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?. Biomolecules. 2023; 13(8). PMC: 10452486. DOI: 10.3390/biom13081178. View

15.

Zhang J, Zhang X, Lin A, Yan W . Lesion HLA-F expression is irrelevant to prognosis for patients with gastric cancer. Hum Immunol. 2013; 74(7):828-32. DOI: 10.1016/j.humimm.2013.03.002. View

16.

Zhang X, Lin A, Zhang J, Bao W, Xu D, Ruan Y . Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma. Int J Cancer. 2012; 132(1):82-9. DOI: 10.1002/ijc.27621. View

17.

Boyle L, Gillingham A, Munro S, Trowsdale J . Selective export of HLA-F by its cytoplasmic tail. J Immunol. 2006; 176(11):6464-72. DOI: 10.4049/jimmunol.176.11.6464. View

18.

Martayan A, Sibilio L, Tremante E, Lo Monaco E, Mulder A, Fruci D . Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells. J Immunol. 2009; 182(6):3609-17. DOI: 10.4049/jimmunol.0802316. View

19.

Goodridge J, Lee N, Burian A, Pyo C, Tykodi S, Warren E . HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway. J Immunol. 2013; 191(4):1567-77. PMC: 3732835. DOI: 10.4049/jimmunol.1300080. View

20.

Khare S, Hansen J, Luthra H, David C . HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest. 1996; 98(12):2746-55. PMC: 507739. DOI: 10.1172/JCI119100. View